Identifying potential modifiable risk factors to reduce the incidence of vascular access
thrombosis in hemodialysis could reduce considerable morbidity and health care costs. We …

This study identifies factors that are associated with the risk of access thrombosis in 267 new
hemodialysis patients. There are few longitudinal studies evaluating the risk of access …

Change in access blood flow over time predicts vascular access thrombosis. Background
Vascular access thrombosis accounts for at least $1 billion dollars in annual expenses and …

Predictive measures of vascular access thrombosis: A prospective study. Malfunction of
permanent vascular accesses remains a cause of frequent and costly morbidity in patients …

Vascular access thrombosis is the most common and costly complication in hemodialysis
patients. The role of thrombophilia in access thrombosis is not established. A case-control …

Vascular access dysfunction is an important cause of morbidity for dialysis patients and a
major contributor to hemodialysis cost. Thrombosis is a leading cause of vascular access …

Factors associated with the prevalence of arteriovenous fistulas in hemodialysis patients in
the HEMO Study. Background Arteriovenous (AV) fistulas are the vascular access of choice …

Several medications have been proposed to improve hemodialysis (HD) vascular access
outcomes based on potentially favorable anticoagulant, antiplatelet, or pleiotropic …

Methods We randomized 103 patients (68 arteriovenous [AV] fistulas, 35
polytetrafluoroethylene [PTFE] grafts) to receive monthly measurement of access flow …

Abstract The Fistula First Initiative set a goal of 66% arteriovenous (AV) fistula-based access
among US hemodialysis patients. This study modeled the impact of achieving the target AV …